Troy A. Ignelzi - Jun 14, 2021 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Financial Officer
Signature
/s/ Troy Ignelzi
Stock symbol
KRTX
Transactions as of
Jun 14, 2021
Transactions value $
-$423,268
Form type
4
Date filed
6/16/2021, 07:01 PM
Previous filing
May 12, 2021
Next filing
Aug 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $20.7K +2.25K +17.29% $9.20* 15.2K Jun 16, 2021 Direct
transaction KRTX Common Stock Sale -$291K -2.25K -14.74% $129.45 13K Jun 16, 2021 Direct
transaction KRTX Common Stock Options Exercise $8.28K +900 +6.92% $9.20* 13.9K Jun 14, 2021 Direct
transaction KRTX Common Stock Sale -$119K -900 -6.47% $132.52 13K Jun 14, 2021 Direct
transaction KRTX Common Stock Options Exercise $3.24K +352 +2.71% $9.20* 13.4K Jun 16, 2021 Direct
transaction KRTX Common Stock Sale -$45.2K -352 -2.64% $128.40 13K Jun 16, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -2.25K -18.31% $0.00 10K Jun 16, 2021 Common Stock 2.25K $9.20 Direct F1
transaction KRTX Option (right to buy) Options Exercise $0 -900 -35.93% $0.00 1.61K Jun 14, 2021 Common Stock 900 $9.20 Direct F1
transaction KRTX Option (right to buy) Options Exercise $0 -352 -21.93% $0.00 1.25K Jun 16, 2021 Common Stock 352 $9.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in thirty-six equal monthly installments beginning on April 1, 2019.